WHO. Coronavirus disease COVID-2019. doi:10.30895/2312-7821-2020-8-1-3-8
Ge H, Wang X, Yuan X, et al. The epidemiology and clinical information about COVID-19. Eur J Clin Microbiol Infect Dis. 2020;39(6):1011-1019. doi:10.1007/s10096-020-03874-z
Worldometer. COVID-19 Coronavirus Pandemic: Coronavirus Cases. https://www.worldometers.info. Published 2020.
Ye Q, Wang B, Mao J. The pathogenesis and treatment of the ‘Cytokine Storm’’ in COVID-19.’ J Infect. 2020;80(6):607-613. doi:10.1016/j.jinf.2020.03.037
Mathivanan S, Fahner CJ, Reid GE, Simpson RJ. ExoCarta 2012: Database of exosomal proteins, RNA and lipids. Nucleic Acids Res. 2012;40(D1):1241-1244. doi:10.1093/nar/gkr828
Camacho L, Guerrero P, Marchetti D. MicroRNA and Protein Profiling of Brain Metastasis Competent Cell-Derived Exosomes. PLoS One. 2013;8(9). doi:10.1371/journal.pone.0073790
Monteiro VVS, Reis JF, Gomes R de S, Navegantes KC, Monteiro MC. Dual behaviour of exosome in septic cardiomyopathy. In: Exosomes in Cardiovascular Diseases, Advances in Experimental Medicine and Biology. 998th ed. Singapore: Springer Nature Singapore; 2017:300. doi:10.1007/978-981-10-4397-0
Essandoh K, Yang L, Wang X, et al. Blockade of exosome generation with GW4869 dampens the sepsis-induced inflammation and cardiac dysfunction. Biochim Biophys Acta - Mol Basis Dis. 2015;1852(11):2362-2371. doi:10.1016/j.bbadis.2015.08.010
Mehta P, Mcauley DF, Brown M, et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395(10229):1033-1034. doi:10.1016/S0140-6736(20)30628-0
Huang M, Yang Y, Shang F, et al. Clinical characteristics and predictors of disease progression in severe patients with COVID-19 infection in Jiangsu Province, China: a descriptive study. Am J Med Sci. 2020;S0002-9629(20):1-23. doi:10.1016/j.amjms.2020.05.038
Zhao Q, Meng M, Kumar R, et al. Lymphopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A systemic review and meta-analysis. Int J Infect Dis. 2020;96:131-135. doi:10.1016/j.ijid.2020.04.086
Zhu Y, Ziqiang D, Zhu Y, Li W, Miao H, Li Z. Evaluation of organ function in patients with severe COVID-19 infections. Med Clin (Barc). 2020. doi:10.1016/j.medcli.2020.05.012
Lippi G, Plebani M, Henry BM. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis. Clin Chim Acta. 2020;506:145-148. doi:10.1016/j.cca.2020.03.022
Bost P, Giladi A, Liu Y, et al. Host-Viral Infection Maps Reveal Signatures of Severe COVID-19 Patients. Cell. 2020. doi:10.1016/j.cell.2020.05.006
Wang L, Liu J, Xie W, et al. Overexpression of MALAT1 Relates to Lung Injury through Sponging miR-425 and Promoting Cell Apoptosis during ARDS. Can Respir J. 2019:1-9. doi:10.1155/2019/1871394
Zdravkovic N, Rosic M, Lutovac M, Zdravkovic V. Physiology and Pathology of Cytokine: Commercial Production and Medical Use. In: Rezi N, ed. Physiology and Pathology of Immunology. London: Intech Open Limited; 2017:33-53. doi:http://dx.doi.org/10.5772/57353
Ye Q, Wang B, Mao J. Cytokine Storm in COVID-19 and Treatment. J Infect. 2020. doi:10.1016/j.jinf.2020.03.037
Sun X, Wang T, Cai D, et al. Cytokine storm intervention in the early stages of COVID-19 pneumonia. Cytokine Growth Factor Rev. 2020;(April):1-5. doi:10.1016/j.cytogfr.2020.04.002
Liu B. Free DNA, a reason for severe COVID-19 infection? Med Hypotheses. 2020;142(April):109812. doi:10.1016/j.mehy.2020.109812
Hirano T, Murakami M. COVID-19: A New Virus, but a Familiar Receptor and Cytokine Release Syndrome. Immunity. 2020;52(5):731-733. doi:10.1016/j.immuni.2020.04.003
Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. doi:10.1016/S0140-6736(20)30183-5
Raucci F, Mansour AA, Casillo GM, et al. Interleukin-17A (IL-17A), a key molecule of innate and adaptive immunity, and its potential involvement in COVID-19-related thrombotic and vascular mechanisms. Autoimmun Rev. 2020;19(April):102572. doi:10.1016/j.autrev.2020.102572
Real JM, Ferreira LRP, Esteves GH, et al. Exosomes from patients with septic shock convey miRNAs related to inflammation and cell cycle regulation: New signaling pathways in sepsis? Crit Care. 2018;22(1):1-11. doi:10.1186/s13054-018-2003-3
Gao K, Jin J, Huang C, et al. Exosomes Derived From Septic Mouse Serum Modulate Immune Responses via Exosome-Associated Cytokines. Front Immunol. 2019;10(July):1-11. doi:10.3389/fimmu.2019.01560
Cesar L, Azevedo P, Janiszewski M, et al. Platelet-derived exosomes from septic shock patients induce myocardial dysfunction. Crit Care. 2007;11(6):1-10. doi:10.1186/cc6176
COVID-19 Treament Guideline Panel. Coronavirus Disease 2019 ( COVID-19 ) Treatment Guidelines. https://www.COVID19treatmentguidelines.nih.gov/. Published 2020. Accessed July 2, 2020.
CDC. Interim Clinical Guidance for Management of Patients with Confirmed Coronavirus Disease. doi:10.1056/NEJMc2009787
Grein J, Ohmagari N, Shin D, et al. Compassionate Use of Remdesivir for Patients with Severe COVID-19. N Engl J Med. 2020;382:2327-2336. doi:10.1056/nejmoa2007016
Theoharides TC, P Conti. Dexamethasone for COVID-19 ? Not so fast. J Biol Regul Homeost Agent. 2020;34(3):1-5. doi:10.23812/20-EDITORIAL
Ren J, He W, Zheng L, Duan H. From structures to functions: Insights into exosomes as promising drug delivery vehicles. Biomater Sci. 2016;4(6):910-921. doi:10.1039/c5bm00583c
Momen-Heravi F, Bala S, Bukong T, Szabo G. Exosome-mediated delivery of functionally active miRNA-155 inhibitor to macrophages. Nanomedicine Nanotechnology, Biol Med. 2014;10(7):1517-1527. doi:10.1016/j.nano.2014.03.014
Miksa M, Wu R, Dong W, et al. Immature Dendritic Cell-Derived Exosomes Rescue Septic Animals Via Milk Fat Globule Epidermal Growth Factor VIII. J Immunol. 2009;183(9):5983-5990. doi:10.4049/jimmunol.0802994
Choi H, Kim Y, Mirzaaghasi A, et al. Exosome-based delivery of super-repressor I k B a relieves sepsis-associated organ damage and mortality. Sci Adv. 2020;6(eaaz6980):1-10.
Song Y, Dou H, Li X, et al. Exosomal miR‐146a Contributes to the Enhanced Therapeutic Efficacy of Interleukin‐1β‐Primed Mesenchy.pdf. Stem Cells Express. 2017;35:1208-1221. doi:http://dx.doi.org/ 10.1002/stem.2564
Tsuchiya A, Takeuchi S, Iwasawa T, et al. Therapeutic potential of mesenchymal stem cells and their exosomes in severe novel coronavirus disease 2019 ( COVID-19 ) cases. Inflamation Regen. 2020;40(14):10-15. doi:10.1186/s41232-020-00121-y
Wu J, Wang Y, Li L. Functional significance of exosomes applied in sepsis: A novel approach to therapy. Biochim Biophys Acta - Mol Basis Dis. 2017;1863(1):292-297. doi:10.1016/j.bbadis.2016.10.024